Humoral Response after Two Doses of BNT162b2 mRNA Vaccine Has a Role in Predicting Response after Three Doses That Is Related to Plasma HIV Viremia and Nadir CD4+ Cell Count in HIV-Positive Patients

We investigated the spike IgG levels of HIV+ patients on antiretroviral therapy six months after they received their second dose (T2) and six months after the third dose (T3) of the BNT162b2 mRNA vaccine, as well as the influence of different levels of plasma HIV viremia of overall CD4+ cell count a...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Monica Basso, Nicole Pirola, Susanna Pascoli, Beatrice Bragato, Antonio Vinci, Marco Iannetta, Francesco Colombo, Nicholas Geremia, Luca Martignago, Maria Cristina Rossi, Ludovica Cipriani, Mario Giobbia, Pier Giorgio Scotton, Saverio Giuseppe Parisi
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	MDPI AG 2022-12-01
Saila:	Vaccines
Gaiak:	HIV infection BNT162b2 mRNA vaccine third dose nadir HIV residual viremia trimeric S-protein antigen
Sarrera elektronikoa:	https://www.mdpi.com/2076-393X/11/1/82
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!